SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-005836
Filing Date
2017-08-03
Accepted
2017-08-03 16:06:19
Documents
69
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vvus-20170630x10q.htm 10-Q 1692192
2 EX-10.1 vvus-20170630ex10181e8e3.htm EX-10.1 338325
3 EX-31.1 vvus-20170630ex31171f944.htm EX-31.1 18428
4 EX-31.2 vvus-20170630ex312f77f52.htm EX-31.2 19781
5 EX-32 vvus-20170630xex32.htm EX-32 14824
  Complete submission text file 0001558370-17-005836.txt   5958436

Data Files

Seq Description Document Type Size
6 EX-101.INS vvus-20170630.xml EX-101.INS 1130312
7 EX-101.SCH vvus-20170630.xsd EX-101.SCH 40334
8 EX-101.CAL vvus-20170630_cal.xml EX-101.CAL 48798
9 EX-101.DEF vvus-20170630_def.xml EX-101.DEF 112370
10 EX-101.LAB vvus-20170630_lab.xml EX-101.LAB 335796
11 EX-101.PRE vvus-20170630_pre.xml EX-101.PRE 249594
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33389 | Film No.: 171004893
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1